IPN10200 treatment for cervical dystonia in adults
Official title: A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants
Run by Ipsen · NCT06937931 · Data updated 2026-11-12
This trial will test whether a single injection of IPN10200 (one of two doses) reduces neck posture problems, pain, and disability better than placebo in adults with cervical dystonia.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | Ipsen Industry-sponsored |
| Locations | 45 sites (Tucson, Arizona and 44 other locations) |
| Status | Recruiting |
| Started | June 30, 2025 |
| Main results expected | March 26, 2027 |
| Study ends | November 5, 2027 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06937931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with isolated cervical dystonia who meet TWSTRS thresholds (Total ≥20; Severity ≥15; Disability ≥3; Pain ≥1) who do not have severe dysphagia or predominant antero/retrocollis are the intended participants, and both BoNT-naïve and previously treated patients may be eligible.
✕Probably not a fit
Patients with severe dysphagia, predominant anterocollis or retrocollis, traumatic or tardive torticollis, marked cervical contractures, or other exclusionary conditions are unlikely to be eligible or to benefit from this investigational treatment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2, placebo-controlled interventional trial enrolls adults with isolated cervical dystonia and required minimum symptom scores on the TWSTRS scale. After a screening period of up to 4 weeks, participants enter a 36-week treatment period in which they receive either IPN10200 (Dose A or Dose B) or placebo on Day 1 and are followed for efficacy and safety outcomes. The protocol allows both patients who are naïve to botulinum toxin (BoNT) and those previously treated with BoNT. Key eligibility limits include exclusion of severe dysphagia, predominant antero- or retrocollis, traumatic or tardive torticollis, and marked cervical contractures.
Why it matters
Potential benefit: If successful, IPN10200 could provide longer-lasting relief of neck posture, pain, and disability than current botulinum toxin injections, reducing how often patients need injections.
How similar studies have gone: Botulinum toxin injections are an established short-term treatment for cervical dystonia but typically last about three months, and long-acting formulations like IPN10200 are relatively novel with limited prior clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A clinical diagnosis of isolated Cervical Dystonia (CD) (idiopathic) characterized by dystonic symptoms localised to the head, neck, and shoulder areas with at least moderate severity at Screening and Baseline (Day 1) defined as: * (a) Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)-Total score ≥20 * (b) TWSTRS-Severity subscale score ≥15 * (c) TWSTRS-Disability subscale score ≥3 * (d) TWSTRS-Pain subscale score ≥ 1 2. Treatment naïve or non-naïve to BoNT therapy for CD Exclusion Criteria: 1. Participants presenting with a swallowing disorder of any origin which might be exacerbated by BoNT treatment, such as: * (a) Grade 3 or 4 on the Dysphagia Severity Scale (severe dysphagia) with swallowing difficulties and requiring a change in diet. 2. Predominant anterocollis. 3. Predominant retrocollis. 4. Traumatic torticollis or tardive torticollis. 5. Marked limitation on passive range of motion that suggests cervical contractures or structural abnormality.
Where it's running
-
Parkinson's & Mvmt Disorders Inst
Fountain Valley, California, United States Recruiting -
Parkinson's Ds & Mvt Disorders Cntr
Boca Raton, Florida, United States Recruiting -
Emory Brain Health Center
Atlanta, Georgia, United States Recruiting -
Rush Medical Center
Chicago, Illinois, United States Recruiting -
Quest Research Institute
Farmington Hills, Michigan, United States Recruiting -
Ichan Sch of Medicine @ Mt. Sinai
New York, New York, United States Recruiting
Show 39 more locations
-
Kingfisher Cooperative
Spokane, Washington, United States Recruiting -
Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika
Brno, Czechia Recruiting -
NEUROHK s.r.o.
Choceň, Czechia Recruiting -
CHU Grenoble Alpes - Site Nord - Neurology
Grenoble, France Recruiting -
CHU Nimes - Hôpital Caremeau
Nîmes, France Recruiting -
Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences)
Toulouse, France Recruiting -
Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie
Haag in Oberbayern, Germany Recruiting -
GFO Kliniken Troisdorf
Troisdorf, Germany Recruiting -
Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna
Bologna, Italy Recruiting -
Istituto Auxologico Italiano - Auxologico San Luca
Milan, Italy Recruiting -
IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione
Pavia, Italy Recruiting -
Futuremeds Krakow
Krakow, Poland Recruiting -
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Poland Recruiting -
Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K.
Oświęcim, Poland Recruiting -
Eskulap Pabianice Sp z o.o.
Pabianice, Poland Recruiting -
ETG Neuroscience Sp. z o.o.
Warsaw, Poland Recruiting -
H.U. Puerta del Mar - Neurocirugía
Cadiz, Spain Recruiting -
Hospital Universitario De La Princesa
Madrid, Spain Recruiting -
Hospital Universitario Virgen del Rocio - Neurofisiología Clínica
Seville, Spain Recruiting -
The Walton Centre
Fazakerley, United Kingdom Recruiting -
University College London Hospitals NHS Foundation Trust - National Hospital for Neurology and Neurosurgery
London, United Kingdom Recruiting -
University of Arizona Health Sciences - Neurology
Tucson, Arizona, United States Active not recruiting -
Loma Linda University School of Medicine - Neurology
Loma Linda, California, United States Withdrawn -
USF Health Byrd Alzheimer's Institute
Tampa, Florida, United States Not yet recruiting -
MINKSneuro s.r.o.
Brno, Czechia Active not recruiting -
Fakultni nemocnice Olomouc - Neurologicka klinika
Olomouc, Czechia Not yet recruiting -
Vseobecna fakultni nemocnice v Praze - Neurologicka klinika
Prague, Czechia Withdrawn -
Timone University Hospital
Marseille, France Active not recruiting -
Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie
Strasbourg, France Active not recruiting -
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany Not yet recruiting -
University Hospital Tuebingen - Neurologie
Tübingen, Germany Active not recruiting -
Istituto Neurologico C. Besta
Milan, Italy Active not recruiting -
Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia
Reggio Emilia, Italy Not yet recruiting -
Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo
Katowice, Poland Withdrawn -
Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego
Wroclaw, Poland Withdrawn -
Hospital de la Santa Creu i Sant Pau - Neurología
Barcelona, Spain Active not recruiting -
Hospital Universitario Ramon y Cajal - Neurologia
Madrid, Spain Withdrawn -
Royal Devon And Exeter Hospital - Neurology
Exeter, United Kingdom Not yet recruiting -
Luton And Dunstable Hospital - Neurology
Luton, United Kingdom Active not recruiting
Study contacts
- Study coordinator: Ipsen Clinical Study Enquiries
- Email: clinical.trials@ipsen.com
- Phone: See e mail
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Targeted Focused Ultrasound for Cervical Dystonia
This trial tests whether applying theta burst focused ultrasound to brain regions GPi or DN, or a sham, can help people with cervical dystonia.
-
Noninvasive brain stimulation for cervical dystonia using continuous theta-burst in a sham-controlled trial
This study tests whether delivering continuous theta-burst stimulation to the brain can reduce neck dystonia symptoms compared with sham stimulation.
-
Vibration to improve head posture in cervical dystonia
This trial will test whether stronger vibration applied to the neck muscles helps correct abnormal head posture in people with cervical dystonia.
-
Adding zinc to Botox for cervical dystonia
This will test whether taking daily zinc citrate after a Botox injection helps people with cervical dystonia keep symptom relief longer.
-
Using Valbenazine with Botulinum Toxin for Cervical Dystonia
This study is testing if adding a medication called valbenazine to botulinum toxin injections can help people with cervical dystonia feel better and improve their quality of life.
-
Exercise program for cervical dystonia patients receiving botulinum toxin
This study tests if a personalized exercise program can help people with cervical dystonia feel better after getting botulinum toxin injections.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.